Skip to main content

Table 1 MR results where glucose, HbA1c and T2DM as the exposure and IBD as the outcome

From: No causal relationship between glucose and inflammatory bowel disease: a bidirectional two-sample mendelian randomization study

Exposure

P

OR(95%CI)

P for Q-Test

P for Intercept

Fasting glucose

    

IVW

0.286

0.858(0.649–1.135)

0.069

0.182

MR Egger

0.596

1.145(0.695–1.887)

  

Simple mode

0.671

0.846(0.392–1.822)

  

Weighted median

0.783

1.053(0.729–1.520)

  

Weighted mode

0.771

1.055(0.736–1.511)

  

HbA1c

    

IVW

0.637

1.046(0.866–1.263)

0.182

0.508

MR Egger

0.703

0.920(0.609–1.388)

  

Simple mode

0.307

0.848(0.629–1.140)

  

Weighted median

0.936

0.991(0.799–1.228)

  

Weighted mode

0.992

0.999(0.795–1.254)

  

T2DM

    

IVW

0.016

0.925(0.868–0.985)

0.111

0.837

MR Egger

0.413

0.939(0.806–1.091)

  

Simple mode

0.379

0.909(0.734–1.123)

  

Weighted median

0.497

0.964(0.866–1.072)

  

Weighted mode

0.486

0.956(0.841–1.084)

  
  1. MR: Mendelian Randomization; IBD: Inflammatory Bowel Disease; T2DM: type 2 diabetes; IVW: inverse variance weighted; OR: odds ratio; CI: confidence interval